Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.34 |
| ▸ | EPOR | P19235 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 2/20 | 0.33 |
| ▸ | PRTN3 | P24158 | 2/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL56887 | 0.92 | L3MBTL1 (0.34) | L3MBTL1BTN3A1EPORELANEPRTN3 | |
| SCHEMBL56935 | 0.91 | ALDH1A1 (0.41) | L3MBTL1ALDH1A1MAPK1BTN3A1EPOR | |
| SCHEMBL56583 | 0.86 | RAB9A (0.41) | RAB9A | |
| SCHEMBL57115 | 0.86 | ATM (0.39) | ALDH1A1BTN3A1ELANEPRTN3RAB9A | |
| SCHEMBL56408 | 0.85 | BTN3A1 (0.37) | BTN3A1ELANEPRTN3 | |
| SCHEMBL56466 | 0.84 | TP53 (0.41) | L3MBTL1BTN3A1ELANEPRTN3 | |
| SCHEMBL57135 | 0.83 | MAPT (0.41) | L3MBTL1ALDH1A1MAPK1BTN3A1ELANE | |
| SCHEMBL56758 | 0.82 | ALDH1A1 (0.39) | ALDH1A1BTN3A1RAB9A | |
| SCHEMBL56614 | 0.82 | MAOB (0.37) | L3MBTL1BTN3A1ELANEPRTN3 | |
| SCHEMBL56920 | 0.82 | MMP2 (0.37) | BTN3A1ELANEPRTN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129557-B2 | Phosphonic acid diester derivative and method for producing thereof | Nagai, Kazuhiro (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20090163725-A1 | PHOSPHONIC ACID DIESTER DERIVATIVE AND METHOD FOR PRODUCING THEREOF | HIRATAKE, GOU (JP) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163725-A1 | PHOSPHONIC ACID DIESTER DERIVATIVE AND METHOD FOR PRODUCING THEREOF | PPA1, G6PD, PHOSPHO1 | L3MBTL1 3435/4885ALDH1A1 1716/4885MAPK1 1065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.